The award-winning Precision Medicine Podcast
Clinical conversations about the effective use of precision medicine for cancer care.
Welcome to Season 2!
Get the latest episode straight to your in-box.
Archive: Season 1
Dr. John Quackenbush Part 2: Embracing Biological Complexity to Realize the Potential of Precision Medicine
In our second podcast with Dr. John Quackenbush, Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health, we delved deeper into his approach to understanding cancer by studying entire gene networks rather than simple mutations. Listen here
Airdate: 03.29.20 | Length: 15:50
The Impact of Precision Medicine on Gastrointestinal Disease
Dr. Arturo Loaiza-Bonilla, Chief Medical Officer and Director of Research for the Cancer Treatment Centers of America in Philadelphia, discusses how precision medicine is changing the treatment of GI cancers. Learn about the personal experiences that inspired his medical career focus and the hidden talent that nearly stole him away. Listen here
Airdate: 03.04.20 | Length: 24.53
Precision Medicine is Here: Preparing a New Generation of Scientists to Apply It
Barbara Fortini, PhD, Program Director for the Master of Science in Human Genetics and Genomic Data Analytics at the Keck Graduate Institute shares what students of biology and genetics need to know today versus what they needed to know a decade ago, and how she sees those skills being applied in a clinical setting. Listen here
Airdate: 02.14.20 | Length: 30:35
Dr. Adam Brufsky shares findings from the recent San Antonio Breast Cancer Symposium and the important role of precision medicine
In this episode of the Precision Medicine Podcast, Dr. Adam Brufsky, Medical Director for the Women’s Cancer Program at the UPMC Hillman Cancer Center shares the newest findings presented in December 2019 at the San Antonio Breast Cancer Symposium (SABCS) and discusses the important role of precision medicine in breast cancer care. Listen here
Airdate: 01.24.20 | Length: 30:50
Dr. John Quackenbush Part 1: Using Massive Data to Approach Precision Medicine Beyond Simple Mutations
In this first episode of season two, Dr. John Quackenbush discusses his approach to understanding what makes cancer cancer by studying entire gene networks rather than simple mutations. Dr. Quackenbush is Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health and one of the first people to have worked on the Human Genome Project.
Airdate: 01.09.20 | Length: 24:10
Airdate: 12.19.19 | Length: 11:52
Dr. Selin Kurnaz of Massive Bio Explains the Need to Operationalize Patient Support in Precision Cancer Care
Dr. Selin Kurnaz, CEO and cofounder of Massive Bio talks with us about the importance of increasing patient accessibility to clinical trials, FDA changes that affect clinical trial matching and the challenge of harmonizing disparate healthcare data for better patient care. Listen here